These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 9455791)
1. Loss of imprinting of igf2 in renal-cell carcinomas. Oda H; Kume H; Shimizu Y; Inoue T; Ishikawa T Int J Cancer; 1998 Jan; 75(3):343-6. PubMed ID: 9455791 [TBL] [Abstract][Full Text] [Related]
2. Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma. Nonomura N; Nishimura K; Miki T; Kanno N; Kojima Y; Yokoyama M; Okuyama A Cancer Res; 1997 Jul; 57(13):2575-7. PubMed ID: 9205056 [TBL] [Abstract][Full Text] [Related]
3. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. Kim KS; Lee YI Cancer Lett; 1997 Nov; 119(2):143-8. PubMed ID: 9570364 [TBL] [Abstract][Full Text] [Related]
4. IGF2 but not H19 shows loss of imprinting in human glioma. Uyeno S; Aoki Y; Nata M; Sagisaka K; Kayama T; Yoshimoto T; Ono T Cancer Res; 1996 Dec; 56(23):5356-9. PubMed ID: 8968084 [TBL] [Abstract][Full Text] [Related]
5. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220 [TBL] [Abstract][Full Text] [Related]
6. Genomic imprinting of IGF2 and H19 in human meningiomas. Müller S; Zirkel D; Westphal M; Zumkeller W Eur J Cancer; 2000 Mar; 36(5):651-5. PubMed ID: 10738131 [TBL] [Abstract][Full Text] [Related]
7. Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II. Kim SJ; Park SE; Lee C; Lee SY; Jo JH; Kim JM; Oh YK Biochim Biophys Acta; 2002 Apr; 1586(3):307-15. PubMed ID: 11997082 [TBL] [Abstract][Full Text] [Related]
8. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor. Yballe CM; Vu TH; Hoffman AR J Clin Endocrinol Metab; 1996 Apr; 81(4):1607-12. PubMed ID: 8636375 [TBL] [Abstract][Full Text] [Related]
9. Loss of imprinting in hepatoblastoma. Rainier S; Dobry CJ; Feinberg AP Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748 [TBL] [Abstract][Full Text] [Related]
10. Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma. Wu MS; Wang HP; Lin CC; Sheu JC; Shun CT; Lee WJ; Lin JT Cancer Lett; 1997 Nov; 120(1):9-14. PubMed ID: 9570380 [TBL] [Abstract][Full Text] [Related]
11. Genomic imprinting of H19 and insulin-like growth factor-2 in pediatric germ cell tumors. Ross JA; Schmidt PT; Perentesis JP; Davies SM Cancer; 1999 Mar; 85(6):1389-94. PubMed ID: 10189147 [TBL] [Abstract][Full Text] [Related]
12. Variable imprinting of H19 and IGF2 in fetal cerebellum and medulloblastoma. Albrecht S; Waha A; Koch A; Kraus JA; Goodyer CG; Pietsch T J Neuropathol Exp Neurol; 1996 Dec; 55(12):1270-6. PubMed ID: 8957451 [TBL] [Abstract][Full Text] [Related]
13. Genomic imprinting of IGF-II and H19 in adult human pancreatic tissues. Micha AE; Hähnel S; Friess H; Büchler MW; Adler G; Gress TM Digestion; 1999; 60(5):477-83. PubMed ID: 10473973 [TBL] [Abstract][Full Text] [Related]
14. Loss of Igf2 imprinting in monoclonal mouse hepatic tumor cells is not associated with abnormal methylation patterns for the H19, Igf2, and Kvlqt1 differentially methylated regions. Ishizaki T; Yoshie M; Yaginuma Y; Tanaka T; Ogawa K J Biol Chem; 2003 Feb; 278(8):6222-8. PubMed ID: 12475990 [TBL] [Abstract][Full Text] [Related]
15. Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors. Kim HT; Choi BH; Niikawa N; Lee TS; Chang SI Am J Med Genet; 1998 Dec; 80(4):391-5. PubMed ID: 9856569 [TBL] [Abstract][Full Text] [Related]
16. Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith-Wiedemann syndrome. Joyce JA; Lam WK; Catchpoole DJ; Jenks P; Reik W; Maher ER; Schofield PN Hum Mol Genet; 1997 Sep; 6(9):1543-8. PubMed ID: 9285792 [TBL] [Abstract][Full Text] [Related]
17. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor. Vu TH; Chuyen NV; Li T; Hoffman AR Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581 [TBL] [Abstract][Full Text] [Related]
18. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665 [TBL] [Abstract][Full Text] [Related]
19. Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis. Cui H; Hedborg F; He L; Nordenskjöld A; Sandstedt B; Pfeifer-Ohlsson S; Ohlsson R Cancer Res; 1997 Oct; 57(20):4469-73. PubMed ID: 9377554 [TBL] [Abstract][Full Text] [Related]
20. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors. Nonomura N; Miki T; Nishimura K; Kanno N; Kojima Y; Okuyama A J Urol; 1997 May; 157(5):1977-9. PubMed ID: 9112575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]